These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1634879)

  • 1. Lack of human immunodeficiency virus type 1 (HIV-1) replication and accumulation of viral DNA in HIV-1-infected T cells blocked in cell replication.
    Tang S; Poulin L; Levy JA
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():933-9. PubMed ID: 1634879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo reverse transcription is a crucial event in cell-to-cell transmission of human immunodeficiency virus.
    Li P; Kuiper LJ; Stephenson AJ; Burrell CJ
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():955-9. PubMed ID: 1378883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytopathic effect of human immunodeficiency virus is independent of high levels of unintegrated viral DNA accumulated in response to superinfection of cells.
    Laurent-Crawford AG; Hovanessian AG
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2619-28. PubMed ID: 8277267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes.
    Sperber K; Kalb TH; Stecher VJ; Banerjee R; Mayer L
    AIDS Res Hum Retroviruses; 1993 Jan; 9(1):91-8. PubMed ID: 8427717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.
    Furtado MR; Callaway DS; Phair JP; Kunstman KJ; Stanton JL; Macken CA; Perelson AS; Wolinsky SM
    N Engl J Med; 1999 May; 340(21):1614-22. PubMed ID: 10341273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells.
    Shirazi Y; Pitha PM
    Virology; 1993 Mar; 193(1):303-12. PubMed ID: 8438572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of the differential restriction of human immunodeficiency virus type 1 replication in neuronal cell lines.
    Hsia K; Spector DH; Spector SA
    J Gen Virol; 1997 Dec; 78 ( Pt 12)():3255-64. PubMed ID: 9400976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells.
    De Maria A; Pantaleo G; Schnittman SM; Greenhouse JJ; Baseler M; Orenstein JM; Fauci AS
    J Immunol; 1991 Apr; 146(7):2220-6. PubMed ID: 1706390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The non-immunosuppressive cyclosporin A analogue SDZ NIM 811 inhibits cyclophilin A incorporation into virions and virus replication in human immunodeficiency virus type 1-infected primary and growth-arrested T cells.
    Mlynar E; Bevec D; Billich A; Rosenwirth B; Steinkasserer A
    J Gen Virol; 1997 Apr; 78 ( Pt 4)():825-35. PubMed ID: 9129655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of viral replication in HIV-1-infected CEM T-cell subclones which are reduced in their ability to form syncytia.
    Gruber MF; Hewlett IK; Simms T; Vujcic L; Manischewitz J; Golding H
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1139-46. PubMed ID: 1380260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cell lines by distinct mechanisms: evidence for decreased stability and aberrant processing of HIV-1 proteins.
    Agy MB; Acker RL; Sherbert CH; Katze MG
    Virology; 1995 Dec; 214(2):379-86. PubMed ID: 8553538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curdlan sulfate and HIV-1. I. In vitro inhibitory effects of curdlan sulfate on HIV-1 infection.
    Aoki T; Kaneko Y; Stefanski MS; Nguyen T; Ting RC
    AIDS Res Hum Retroviruses; 1991 Apr; 7(4):409-15. PubMed ID: 1676899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication of adeno-associated virus type 2 in human lymphocytic cells and interaction with HIV-1.
    Mendelson E; Grossman Z; Mileguir F; Rechavi G; Carter BJ
    Virology; 1992 Apr; 187(2):453-63. PubMed ID: 1372138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus type 1 DNA synthesis, integration, and efficient viral replication in growth-arrested T cells.
    Li G; Simm M; Potash MJ; Volsky DJ
    J Virol; 1993 Jul; 67(7):3969-77. PubMed ID: 8099628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells.
    Tsai WP; Conley SR; Kung HF; Garrity RR; Nara PL
    Virology; 1996 Dec; 226(2):205-16. PubMed ID: 8955040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autographa californica nucleopolyhedrovirus infection results in Sf9 cell cycle arrest at G2/M phase.
    Braunagel SC; Parr R; Belyavskyi M; Summers MD
    Virology; 1998 Apr; 244(1):195-211. PubMed ID: 9581791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.
    Connor RI; Chen BK; Choe S; Landau NR
    Virology; 1995 Feb; 206(2):935-44. PubMed ID: 7531918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation.
    Chowers MY; Pandori MW; Spina CA; Richman DD; Guatelli JC
    Virology; 1995 Oct; 212(2):451-7. PubMed ID: 7571414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.